Pavmed logo

Pavmed Share Price Today

(NASDAQ: PAVM)

Pavmed share price is $0.66 & ₹57.40 as on 6 Mar 2025, 2.30 'hrs' IST

$0.66

Market is closed - opens 8 PM, 06 Mar 2025

View live Pavmed share price in Dollar and Rupees. Guide to invest in Pavmed stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pavmed, along with analyst recommendations, forecasts, and comprehensive financials.

Pavmed share price movements

  • Today's Low: $0.60
    Today's High: $0.68

    Day's Volatility :11.28%

  • 52 Weeks Low: $0.57
    52 Weeks High: $3.16

    52 Weeks Volatility :81.9%

Pavmed (PAVM) Returns

PeriodPavmed IncSector (Health Care)Index (Russel 2000)
3 Months
-31.79%
2.1%
0.0%
6 Months
-43.1%
-4.1%
0.0%
1 Year
-76.6%
2.2%
0.0%
3 Years
-96.72%
11.8%
-11.6%

Pavmed (PAVM) Key Statistics

in dollars & INR

Previous Close
$0.66
Open
$0.6763
Today's High
$0.6797
Today's Low
$0.603
Market Capitalization
$9.4M
Today's Volume
$14.7K
52 Week High
$3.16
52 Week Low
$0.5719
Revenue TTM
$4.0M
EBITDA
$-53.8M
Earnings Per Share (EPS)
$-1.14
Profit Margin
602.98%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1358.06%

How to invest in Pavmed Stock (PAVM) from India?

It is very easy for Indian residents to invest directly in Pavmed from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pavmed stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pavmed or PAVM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pavmed or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pavmed shares which would translate to 1.318 fractional shares of Pavmed as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pavmed, in just a few clicks!

Returns in Pavmed (PAVM) for Indian investors in Rupees

The Pavmed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pavmed investment value today

Current value as on today

₹28,367

Returns

₹71,633

(-71.63%)

Returns from Pavmed Stock

₹76,596 (-76.6%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Pavmed (PAVM)

5%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Pavmed Stock from India on INDmoney has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Pavmed

  • First Manhattan Co. LLC

    5.13%

  • Vanguard Group Inc

    0.60%

  • Geode Capital Management, LLC

    0.58%

  • BlackRock Inc

    0.53%

  • Obermeyer Asset Management Co

    0.16%

  • State Street Corp

    0.15%

Analyst Recommendation on Pavmed

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Pavmed(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Pavmed Stock (PAVM)

What analysts predicted

Upside of 1263.64%

Target:

$9.00

Current:

$0.66

Insights on Pavmed Stock (Ticker Symbol: PAVM)

  • Price Movement

    In the last 1 year, PAVM stock has moved down by -78.6%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 979.0K → 996.0K (in $), with an average increase of 1.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -15.21M → 64.39M (in $), with an average increase of 78.7% per quarter
  • PAVM vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 54.6% return, outperforming this stock by 133.2%
  • PAVM vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 135.7% return, outperforming this stock by 232.4%
  • Price to Sales

    ForPAVM every $1 of sales, investors are willing to pay $1.5, whereas for Boston Scientific Corp., the investors are paying $9.1 for every $1 of sales.

Pavmed Technicals Summary

Sell

Neutral

Buy

Pavmed is currently in a neutral trading position according to technical analysis indicators.

Pavmed (PAVM) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pavmed Inc logo
0.0%
-43.1%
-76.6%
-96.72%
-98.2%
Medtronic Plc logo
2.26%
4.07%
8.74%
-12.76%
0.68%
Edwards Lifesciences Corp. logo
0.07%
8.12%
-19.19%
-34.12%
12.08%
Boston Scientific Corp. logo
0.07%
27.33%
53.68%
143.5%
203.93%
Stryker Corporation logo
-0.63%
8.92%
9.84%
53.87%
125.87%
Abbott Laboratories logo
7.11%
21.64%
15.28%
15.75%
78.63%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pavmed Inc logo
NA
NA
0.0
-2.69
-13.58
-0.96
NA
-0.76
Medtronic Plc logo
28.75
28.75
1.87
5.45
0.08
0.05
0.03
38.49
Edwards Lifesciences Corp. logo
30.5
30.5
5.57
2.45
0.17
0.08
NA
16.99
Boston Scientific Corp. logo
83.9
83.9
1.85
2.86
0.09
0.05
NA
14.76
Stryker Corporation logo
50.89
50.89
2.85
13.49
0.15
0.07
0.01
54.1
Abbott Laboratories logo
18.34
18.34
2.52
5.15
0.31
0.06
0.02
27.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pavmed Inc logo
Buy
$9.4M
-98.2%
NA
602.98%
Medtronic Plc logo
Buy
$120.9B
0.68%
28.75
12.83%
Edwards Lifesciences Corp. logo
Buy
$42.0B
12.08%
30.5
76.75%
Boston Scientific Corp. logo
Buy
$154.8B
203.93%
83.9
11.07%
Stryker Corporation logo
Buy
$150.7B
125.87%
50.89
13.25%
Abbott Laboratories logo
Buy
$238.6B
78.63%
18.34
31.95%

About Pavmed

PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Organization
Pavmed
Employees
107
CEO
Dr. Lishan Aklog M.D.
Industry
Health Technology

Management People of Pavmed

NameTitle
Dr. Lishan Aklog M.D.
Chairman & CEO
Mr. Dennis M. McGrath CPA
President & CFO
Mr. Shaun M. O'Neill M.B.A.
Executive VP & COO
Mr. Michael Adam Gordon
Executive VP, General Counsel & Secretary
Dr. Brian J. deGuzman M.D.
Executive VP, Chief Technology & Compliance Officer
Dr. Suman M. Verma M.D., Ph.D.
Senior VP of Molecular Genetics & Chief Scientific Officer
Dr. Deepika A. Lakhani Ph.D.
Senior VP, Chief Regulatory & Quality Officer
Dr. Victoria T. Lee M.D.
Senior VP & Chief Medical Officer

Important FAQs about investing in PAVM Stock from India :

What is Pavmed share price today?

Pavmed share price today stands at $0.66, Open: $0.68 ; Previous Close: $0.66 ; High: $0.68 ; Low: $0.60 ; 52 Week High: $3.16 ; 52 Week Low: $0.57.

The stock opens at $0.68, after a previous close of $0.66. The stock reached a daily high of $0.68 and a low of $0.60, with a 52-week high of $3.16 and a 52-week low of $0.57.

Can Indians buy Pavmed shares?

Yes, Indians can invest in the Pavmed (PAVM) from India.

With INDmoney, you can buy Pavmed at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pavmed at zero transaction cost.

How can I buy Pavmed shares from India?

It is very easy to buy Pavmed from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pavmed (PAVM) be purchased?

Yes, you can buy fractional shares of Pavmed with INDmoney app.

What are the documents required to start investing in Pavmed stocks?

To start investing in Pavmed, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pavmed Stock (PAVM)?

Today’s highest price of Pavmed (PAVM) is $0.68.

Today’s lowest price of Pavmed (PAVM) is $0.60.

What is today's market capitalisation of Pavmed?

Today's market capitalisation of Pavmed PAVM is 9.4M

What is the 52 Week High and Low Range of Pavmed Stock (PAVM)?

  • 52 Week High

    $3.16

  • 52 Week Low

    $0.57

What are the historical returns of Pavmed (PAVM)?

  • 1 Month Returns

    0%

  • 3 Months Returns

    -43.1%

  • 1 Year Returns

    -76.6%

  • 5 Years Returns

    -98.2%

Who is the Chief Executive Officer (CEO) of Pavmed ?

Dr. Lishan Aklog M.D. is the current Chief Executive Officer (CEO) of Pavmed.